Results

In accordance with the March 2020 decision by USP to remand the 2019 revisions of General Chapters Pharmaceutical Compounding – Nonsterile Preparations and Pharmaceutical Compounding – Sterile Preparations, the USP is committed to gathering stakeholder feedback and proceeding in a transparent manner as the expert committees evaluate the course of action.

Drug and supply shortages are an ongoing problem that pharmacies face, and this year, with the COVID-19 crisis, the situation has only gotten worse. Shortages in supply lead to concerns with questionable products in the marketplace; USP 797 standards can help mitigate those concerns.

I am excited to join Wolters Kluwer's team of clinical experts as the resident compliance expert! My career spans 17 years in health systems pharmacy clinical services and general operations, focused in the areas of oncology and infusion services. Most recently, I provided USP consulting services, education and advocacy for quality and regulatory compliance services within the division of Pharmacy Advisory Services at Premier, Inc.

The NIOSH list prevents exposure to hazardous drugs in healthcare workers. Here's how the 2020 NIOSH update, and its effect on USP 800, could impact your practice.